Methylenetetrahydrofolate reductase polymorphism, folate, and susceptibility to preeclampsia

Journal of the Society for Gynecologic Investigation

Volumn 6, Issue 2, 1999, Pages 74-79

  Powers, Robert W ^a   Minich, Leslie A ^a   Lykins, Dave L ^a   Ness, Roberta B ^b   Crombleholme, William R ^a   Roberts, James M ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Folate; Methylenetetrahydrofolate reductase (MTHFR); Missense mutation; Preeclampsia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); DNA; FOLIC ACID;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FETUS; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM;

DNA; FEMALE; FETAL BLOOD; FOLIC ACID; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); OXIDOREDUCTASES ACTING ON CH-NH GROUP DONORS; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PRE-ECLAMPSIA; PREGNANCY;

EID: 0032923636     PISSN: 10715576     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-5576(98)00052-5     Document Type: Article

References (33)

1. Roberts J.M., Taylor R.N., Musci T.J., Rodgers G.M., Hubel C.A., McLaughlin M.K. Preeclampsia An endothelial cell disorder . Am J Obstet Gynecol. 161:1989;1200-1204.
2. Roberts J.M., Redman C.W. Pre-eclampsia More than pregnancy-induced hypertension . Lancet. 341:1993;1447-1451.
3. Cooper D.W., Brennecke S.P., Wilton A.N. Genetics of preeclampsia. Hypertension Pregnancy. 12:1993;1-23.
4. Liston W.A., Kilpatrick D.C. Is genetic susceptibility to preeclampsia conferred by homozygosity for the same single recessive gene in mother and fetus? Br J Obstet Gynaecol. 98:1991;1079-1086.
5. Brattstrom L.E., Hardebo J.E., Hultberg B.L. Moderate homocysteinemia - a possible risk factor for arteriosclerotic cerebrovascular disease. Stroke. 15:1984;1012-1016.
6. Mayer E.L., Jacobsen D.W., Robinson K. Homocysteine and coronary atherosclerosis. J Am Coll Cardiol. 27:1996;517-527.
7. Graham I.M., Daly L.E., Refsum H.M., et al. Plasma homocysteine as a risk factor for vascular disease The European Concerted Action Project . JAMA. 277:1997;1775-1781.
8. Harpel P.C., Zhang X., Borth W. Homocysteine and hemostasis Pathogenetic mechanisms predisposing to thrombosis . J Nut. 126:(Suppl 4):1996;1285-1289.
9. Stamler J.S., Osborne J.A., Jaraki O., et al. Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest. 91:1993;308-318.
10. Upchurch G.R., Welch G.N., Fabian A.J., et al. Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathionine peroxidase. J Biol Chem. 272:1997;17012-17017.
11. Loscalzo J. The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest. 98:1996;5-7.
12. Hirano K., Ogihara T., Miki M., et al. Homocysteine induces iron-catalyzed lipid peroxidation of low-density lipoprotein that is prevented by alpha-tocopherol. Free Radic Res. 21:1994;267-276.
13. Goddijn-Wessel T.A.W., Woulers M., Molen E., et al. Hyperhomocysteinemia A risk factor for placental abruption or infarction . Eur J Obstet Gynecol Reprod Biol. 66:1996;23-29.
14. Steegers-Theunissen R.P.M., Boers G.H.J., Trijbels J.M.F., Eskes T.K.A.B. Hyperhomocysteinemia and recurrent abortion or abruptio placentae. Lancet. 339:1992;1122-1123.
15. Burke G., Robinson K., Refsum H., Stuart B., Drumm J., Graham I. Intrauterine growth retardation, perinatal death, and maternal homocysteine levels. N Engl J Med. 326:1992;69-70.
16. Rosenquist T.H., Ratashak S.A., Selhub J. Homocysteine induces congenital defects of the heart and neural tube Effect of folic acid . Proc Natl Acad Sci USA. 93:1996;15227-15232.
17. Mills J.L., Scott J.M., Kirke P.N., et al. Homocysteine and neural tube defects. J Nut. 126:1996;756S-760S.
18. Dekker G.A., de Vries J.I.P., Doelitzsch P.M., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol. 173:1995;1042-1048.
19. Rajkovic A., Catalano P.M., Malinow M.R. Elevated homocyst(e)ine levels with preeclampsia. Obstet Gynecol. 90:1997;168-171.
20. Powers R.W., Evans R.W., Majors A.K., et al. Plasma homocysteine is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol. 179:1998;1605-1611.
21. Jacques P.F., Bostom A.G., Williams R.R., et al. Relation between folate status, a common mutation in methylenetetrahydrofolate reductase, and plasma homocysteine concentrations. Circulation. 93:1996;7-9.
22. Harmon D.L., Woodside J.V., Yarnell J.W.G., et al. The common "thermolabile" variant of methylenetetrahydrofolate reductase is a major determinant of mild hyperhomocysteinemia. Q J Med. 89:1996;571-577.
23. Kluijtmans L.A.J., van den Heuvel L., Boers G., et al. Molecular genetic analysis in mild hyperhomocysteinemia A common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease . Am J Hum Gen. 58:1996;35-41.
24. Grandone E., Margaglione M., Colaizzo D., et al. Factor V Leiden, C>T MTHFR polymorphism and genetic susceptibility to preeclampsia. Thromb Haemost. 77:1997;1052-1054.
25. Sohda S., Arinami T., Hamada H., Yamada N., Hamaguchi H., Kubo T. Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia. J Med Gene. 34:1997;525-526.
26. Gifford R.W., August P., Chesley L.C. National High Blood Pressure Education Program Working Group report on high blood pressure in pregnancy. Am J Obstet Gynecol. 163:1990;1691-1712.
27. Martin J.N., Blake P.G., Perry K.G., McCaul J.F., Hess L.W., Martin R.W. The natural history of HELLP syndrome Patterns of disease progression and regression . Am J Obstet Gynecol. 164:1991;1500-1513.
28. Steegers-Theunissen R.P.M., Wathen N.C., Eskes T.K.A.B., van Raaji-Selten B., Chard T. Maternal and fetal levels of methionine and homocysteine in early human pregnancy. Br J Obstet Gynaecol. 104:1997;20-24.
29. Christensen B., Frosst P., Lussier Cacan S., et al. Correlation of a common mutation in the methylenetetrahydrofolate reductase gene with plasma homocysteine in patients with premature coronary artery disease. Arterioscler Thromb Vasc Biol. 17:1997;569-573.
30. Jonsdottir L.S., Argrimsson R., Geirsson R.T., Sigvaldason J., Sigfusson N. Death rates from ischemic heart disease in women with a history of hypertension in pregnancy. Acta Obstet Gynecol Scand. 74:1995;772-776.
31. Berglund L., Andersson J., Lilja A., et al. Amino acid transport across the placenta measured by positron emission tomography and analyzed by compartment modeling. J Perinat Med. 18:1990;89-100.
32. Andersson A., Hultberg B., Brattstrom L., Isaksson A. Decreased serum homocysteine in pregnancy. Eur J Clin Chem Clin Biochem. 30:1992;377-379.
33. Hamilton M, Varner M, Ward K. A common mutation which causes hyperhomocysteinemia is not associated with pregnancy induced hypertension. In: International Society for the Study of Hypertension in Pregnancy, 1996.